NEXT Biometrics Group ASA — Remuneration Information 2019

May 27, 2019

NEXT Biometrics Group ASA – Grant of share options to the board of directors

NEXT Biometrics Group ASA – Grant of share options to the board of directors

NEXT Biometrics Group ASA ("Next" or the "Company") has entered into separate share option agreements with each of the directors (incl. the chairperson) of the Company, pursuant to a resolution adopted by the annual general meeting of the Company on 21 May 2019.

The following primary insiders are granted share options:

Magnus Mandersson (chairperson) was granted 50,000 options, following which Magnus Mandersson holds in total 50,000 options and 0 shares in the Company.

Brita Eilertsen (director) was granted 30,000 options, following which Brita Eilertsen holds in total 30,000 options and 0 shares in the Company.

Emine Lundkvist (director) was granted 30,000 options, following which Emine Lundkvist holds in total 30,000 options and 29,738 shares in the Company.

Emanuel Lang (director) was granted 30,000 options, following which Emanuel Lang holds in total 30,000 options. In addition, Greenbridge Investment LP, which is represented on the board of directors of Next by Emanuel Lang holds 7,413,614 shares in the Company.

Petter Fjellstad (director) was granted 30,000 options, following which Petter Fjellstad holds in total 30,000 options and 0 shares in the Company.

The share option agreements includes the following key terms:

-each option gives the option holder the right to subscribe for or purchase one share in the Company;

-the exercise price shall be equal to the average volume-weighted market price of the shares over the five last trading days prior to the date of the grant, plus 10% (VWAP last five trading days before grant NOK 7,67 + 10% = 8,44);

-the options will vest over a period of two years from grant;

-in the event any of the directors resigns or declines re-election during the vesting period, the number of share options shall be reduced pro-rata, however, this shall not apply if the director is available for re-election, but is not elected by the general meeting;

Following the grant, the total number of outstanding share options in the Company is 1,200,000.